: A biotechnology firm with a Consensus Rating of "Buy" and an estimated price target of $4.75, representing a possible 185% upside .
According to the FinanceCharts April 2026 Screener , these stocks have delivered extreme short-term returns:
Beyond analyst ratings, some stocks show strong technical signals or sector-driven interest: $2 stocks to buy now
“TRX shares are trading below $2 and are up more than 300% over the past year... the stock's momentum has been supported by improving operational results rather than speculation alone.” FinanceBuzz · 3 months ago Best Stocks Under $2 Right Now - MarketBeat
: Boasts a 1,850% return this year. Perspective on Penny Stock Risks : A biotechnology firm with a Consensus Rating
: This biotech company hit a 52-week high of $2.08 in early 2026. It holds a "Strong Buy" rating from some analysts with targets as high as $7.00.
: Focused on uranium mining, this stock is well-positioned for growing energy demands. It holds a "Buy" rating with a target price of $2.50. Perspective on Penny Stock Risks : This biotech
: A health care company with YTD returns exceeding 2,100% .